Krzysztof is an accomplished geriatrician and researcher who has dedicated his career to studying the medical aspects of aging. He was born and raised in Eugene, Oregon, USA where he received his primary and secondary education. In 2005, he graduated with honors from the University of Oregon, Clark Honors College, with a BS in Biochemistry. During his time at the university, Krzysztof developed a keen interest in biotechnology and information technology, which he later incorporated into his work in medicine.
After completing his undergraduate studies, Krzysztof attended the Jagiellonian University Collegium Medicum in Krakow, Poland, where he earned his MD degree. He then completed a one-year medical internship and passed the National Medical Board Exam which allowed him to practice medicine in European Union. Later, he passed the United States Medical Licensing Examinations (Step 1, Step 2 CS, Step 2 CK, Step 3 in 2019), which allowed him to practice medicine in the United States.
Since he is licensed to practice medicine in both the European Union and the United States, it gives him the ability to bring his expertise to patients in both regions. In addition to his work in medicine, Krzysztof started a successfull online family business and has also led several online business ventures and continues to develop innovative technology solutions.
After spending some time in USA running his online business, Krzysztof resumed, in 2014, his medical career in Poland, working as a resident doctor at the Upper Silesian Medical Center (GCM) - University Teaching Hospital in Katowice. He simultaneously took on a Research Assistant role at the Silesian Medical University in Katowice, further developing his expertise in geriatrics.
By 2017, Krzysztof was promoted to the position of attending physician at the Geriatrics Ward of the GCM Hospital and continued his research at the Geriatrics Department of the Silesian Medical University. In 2021, he earned his Ph.D. from the Silesian Medical University and began serving as an Assistant Professor.
Throughout his career, Krzysztof has published over 25 scientific papers in major medical journals, contributing to the growing knowledge base on aging and its medical implications. His dedication to his work and interests in biotechnology and information technology have shaped his career, while his love for hiking, traveling, and volunteering has enriched his personal life.
Krzysztof is leading research focused on the use of miRNA and other biomarkers for early diagnosis of Alzheimer's disease. This work aims to identify and analyze specific microRNAs (miRNAs), which are small non-coding RNA molecules that play a crucial role in regulating gene expression. By examining these miRNAs, Krzysztof's research team hopes to uncover unique biomarkers that can serve as early indicators of Alzheimer's disease, even before the onset of noticeable symptoms.
The importance of early detection in Alzheimer's disease cannot be overstated, as it allows for more effective interventions and treatment plans. Krzysztof's work has the potential to transform the way Alzheimer's disease is diagnosed and managed, ultimately improving the quality of life for millions of patients worldwide.
Collaborating with a multidisciplinary team of experts, including molecular biologists, neurologists, and bioinformatics specialists, Krzysztof's research delves into the complex molecular mechanisms underlying Alzheimer's disease. His team is also investigating other potential biomarkers, such as blood-based proteins and neuroimaging markers, to enhance diagnostic accuracy and provide a more comprehensive understanding of this debilitating condition.
In addition, Krzysztof's research focuses on understanding the complex interplay of cognitive, emotional, and behavioral disturbances that significantly impact the quality of life for older individuals. This area of research is particularly important due to the high prevalence of these symptoms among the aging population and the associated burden on patients, caregivers, and healthcare systems. The goal of this research is to identify novel biomarkers, and develop targeted interventions to improve the detection, management, and treatment of neuropsychiatric symptoms in geriatric patients.
